Journal: Molecular Psychiatry
Affiliations: 5Go to article
Molecular routes to rescuing memory
© MOLEKUUL/SCIENCE PHOTO LIBRARY/Getty
A protein associated with intellectual disabilities could also be behind the onset of Alzheimer’s disease.
Drugs that destroy the build-up of beta amyloid, or ‘senile plaque’, in Alzheimer’s patients have yet to improve memory and brain function.
A team led by researchers from Tokyo Medical and Dental University has found that, just before the growth of senile plaque in mice developing Alzheimer’s, the protein SRRM2 underwent chemical changes that reduced levels of PQBP1, a protein linked to intellectual disabilities.
The team bred mice with a mutated PQBP1 gene, which modified synapse structures in the mice’s brains and disrupted communication between neurons. Supplementing Alzheimer’s mice with PQBP1 proteins recovered the synapse structure and improved their brain function.
Uncovering the molecules and mutations that precede the onset of Alzheimer’s could lead to targeted gene therapies.
- Molecular Psychiatry 23, 2090–2110 (2018). doi: 10.1038/s41380-018-0253-8
|Tokyo Medical and Dental University (TMDU), Japan||0.58|
|Juntendo University, Japan||0.17|
|RIKEN Center for Brain Science (CBS), Japan||0.17|
|Jichi Medical University, Japan||0.08|